Skip to main content

Jaihwan Kim

Seoul National University · Medicine

About the Lab

Professor Jaihwan Kim's research lab specializes in gastrointestinal oncology and interventional endoscopy, with a strong focus on pancreatic and biliary tract cancers. The lab investigates diagnostic and therapeutic strategies for malignant biliary obstruction and metastatic pancreatic cancer, emphasizing endoscopic techniques like EUS-FNA and ERCP, as well as systemic chemotherapy regimens such as FOLFIRINOX and GNP. Key research directions include identifying molecular targets (e.g., Cdc6) involved in tumor progression and exploring clinical outcomes based on patient-specific factors like gender and treatment response. The lab also examines post-surgical complications, such as post-gastrectomy gallstone formation, to improve long-term patient management.

pancreatic cancerendoscopic ultrasoundFOLFIRINOXbiliary obstructiongallstone formation

Research Overview

Papers
200
Total Citations
2,384
Papers (5y)
50
Primary Field
Medicine

Research Output Trend

Figures are computed from collected data and may differ slightly.

Publications per year (5y)
50total
2022
2023
2024
2025
2026
Citations per year (5y)
243total
20222023202420252026

Selected Papers

15
1
Article|69 citations·2011
Clinical features of 20 patients with curatively resected biliary neuroendocrine tumours
Jaihwan Kim, Woo Jin Lee, Sang Hyub Lee, Kyoung Bun Lee, Ji Kon Ryu, Yong‐Tae Kim, Sun‐Whe Kim, Yong Bum Yoon, Jin‐Hyeok Hwang, Ho‐Seong Han, Sang Myung Woo, Sang‐Jae Park
SJR Q1Digestive and Liver Disease
EpidemiologyMedicine
2
Article|67 citations·2016
Percutaneous transhepatic versus EUS-guided gallbladder drainage for malignant cystic duct obstruction
Jin Ho Choi, Hyoung Woo Kim, Jong-Chan Lee, Kyu-hyun Paik, Nak Jong Seong, Chang Jin Yoon, Jin‐Hyeok Hwang, Jaihwan Kim
SJR Q1Gastrointestinal Endoscopy
Pulmonary and Respiratory MedicineMedicine
3
Article|57 citations·2018
Same‐session endoscopic ultrasound‐guided fine needle aspiration and endoscopic retrograde cholangiopancreatography‐based tissue sampling in suspected malignant biliary obstruction: A multicenter experience
Jung Hyun Jo, Chang Min Cho, Jae Hyuck Jun, Moon Jae Chung, Tae Hyeon Kim, Dong Wan Seo, Jaihwan Kim, Do Hyun Park
SJR Q1Journal of Gastroenterology and HepatologyOA

BACKGROUND AND AIM: Few studies compared endoscopic ultrasound (EUS)-guided fine needle aspiration (EUS-FNA) with endoscopic retrograde cholangiopancreatography (ERCP)-based tissue sampling in terms of diagnostic accuracy in suspected malignant biliary obstruction. We evaluated and compared the diagnostic performance of EUS-FNA and ERCP-based tissue sampling. METHODS: This multicenter study included 263 patients with suspected malignant biliary obstruction who underwent same-session EUS and ERCP

Pulmonary and Respiratory MedicineMedicine
4
Article|50 citations·2019
Clinical Factors Associated With Gastric Cancer in Individuals With Lynch Syndrome
Jaihwan Kim, Danielle Braun, Chinedu Ukaegbu, Tara G. Dhingra, Fay Kastrinos, Giovanni Parmigiani, Sapna Syngal, Matthew B. Yurgelun
SJR Q1Clinical Gastroenterology and HepatologyOA
Pathology and Forensic MedicineMedicine
5
Article|35 citations·2012
Clinical outcomes of patients who experienced perforation associated with endoscopic retrograde cholangiopancreatography
Jaihwan Kim, Sang Hyub Lee, Woo Hyun Paik, Byeong Jun Song, Jin‐Hyeok Hwang, Ji Kon Ryu, Yong‐Tae Kim, Yong Bum Yoon
SJR Q1Surgical Endoscopy
Pulmonary and Respiratory MedicineMedicine
6
Article|34 citations·2020
Comparison of FOLFIRINOX and Gemcitabine Plus Nab-paclitaxel for Treatment of Metastatic Pancreatic Cancer
Jong-Chan Lee, Sang Myung Woo, Dong Woo Shin, Jinkook Kim, Se Yeol Yang, Min Jae Kim, Jin Won Kim, Ji‐Won Kim, Woo Jin Lee, Hyo Soung, Philiip Park, Jaihwan Kim
SJR Q3American Journal of Clinical Oncology

OBJECTIVE: By using the Korean Pancreatic Cancer (K-PaC) registry, we compared the clinical outcomes of FOLFIRINOX (FFX) and gemcitabine plus nab-paclitaxel (GNP) in patients with metastatic pancreatic cancer (MPC). METHODS: We constructed a web-based database of 3748 anonymized patients diagnosed with pancreatic ductal adenocarcinoma. MPC patients who received first-line FFX or GNP were enrolled. Overall survival (OS), progression-free survival, grade III to IV toxicity, and cross-over treatmen

OncologyMedicine
7
Article|28 citations·2020
Cdc6 disruption leads to centrosome abnormalities and chromosome instability in pancreatic cancer cells
Yuna Youn, Jong-Chan Lee, Jaihwan Kim, Jae Kim, Jin‐Hyeok Hwang, Jae Kim, Jin‐Hyeok Hwang
SJR Q1Scientific ReportsOA

Abstract Cell division cycle 6 ( Cdc6 ) plays key roles in regulating DNA replication, and activation and maintenance of cell cycle check points. In addition, Cdc6 exerts oncogenic properties via genomic instability associated with incomplete DNA replication. This study aimed to examine the effects of Cdc6 on pancreatic cancer (PC) cells. Our results showed that Cdc6 expression was higher in clinical PC specimens (based on analysis of the GEPIA database) and cell lines, and the high Cdc6 express

Molecular BiologyBiochemistry, Genetics and Molecular Biology
8
Article|26 citations·2011
Results of repeat endoscopic retrograde cholangiopancreatography after initial biliary cannulation failure following needle‐knife sphincterotomy
Jaihwan Kim, Ji Kon Ryu, Dong‐Won Ahn, Joo Kyung Park, Won Jae Yoon, Yong‐Tae Kim, Yong Bum Yoon
SJR Q1Journal of Gastroenterology and Hepatology

BACKGROUND AND AIM: After failed biliary cannulation with needle knife sphincterotomy (NKS), endoscopic retrograde cholangiopancreatography (ERCP) is sometimes repeatedly performed in clinically stable patients; however, there are few reports about the results. This study assessed the results of repeated ERCPs after failure with NKS. METHODS: After failed NKS, patients who underwent repeated ERCP for the same purpose within 3 days were retrospectively identified. Success was defined as deep plac

Pulmonary and Respiratory MedicineMedicine
9
Article|26 citations·2016
Risk Factors for Gallstone Formation in Resected Gastric Cancer Patients
Kyu-hyun Paik, Jong-Chan Lee, Hyung Woo Kim, Jingu Kang, Yoon Suk Lee, Jin‐Hyeok Hwang, Sang Hoon Ahn, Do Joong Park, Hyung‐Ho Kim, Jaihwan Kim
SJR Q3MedicineOA

Previous studies reported increased incidence of gallstone formation after gastrectomy. However, there were few reports about factors other than surgical technique. The purpose of this study is to investigate the spectrum of risk factors of gallstone formation after gastrectomy. From June 2003 to December 2008, 1480 patients who underwent gastrectomy due to gastric cancer but had no gallstones before surgery were identified. Electronic medical records were retrospectively reviewed. Gallstones we

Pulmonary and Respiratory MedicineMedicine
10
Article|22 citations·2010
Self-expandable metallic stent placement for malignant obstruction in patients with locally recurrent gastric cancer
Jaihwan Kim, Il Ju Choi, Chan Gyoo Kim, Jong Yeul Lee, Soo‐Jeong Cho, Sook Ryun Park, Jun Ho Lee, Keun Won Ryu, Young‐Woo Kim, Young-Iee Park
SJR Q1Surgical Endoscopy
SurgeryMedicine
11
Article|20 citations·2016
Predictors of Increased Risk of Hepatocellular Carcinoma in Patients with Type 2 Diabetes
Won Keun, Jung Wha Chung, Cho Jun-Hyeon, Joo Yeong Baeg, Eun Sun Jang, Hyuk Yoon, Jaihwan Kim, Jaihwan Kim, Cheol Min Shin, Young Soo Park, Jin‐Hyeok Hwang, Sook‐Hyang Jeong
SJR Q1PLoS ONEOA

Epidemiological data indicate that type 2 diabetes is associated with increased risk of hepatocellular carcinoma (HCC). However, risk stratification for HCC has not been fully elucidated in diabetic population. The aim of this study was to identify potential predictors of HCC in diabetic patients without chronic viral hepatitis. A cohort of 3,544 diabetic patients without chronic viral hepatitis or alcoholic cirrhosis was established and subjects were randomly allocated into a derivation and a v

EpidemiologyMedicine
12
Article|20 citations·2015
Postoperative Carcinoembryonic Antigen as a Complementary Tumor Marker of Carbohydrate Antigen 19-9 in Pancreatic Ductal Adenocarcinoma
Jaihwan Kim, Yoon Suk Lee, In Kyeom Hwang, Bong Kyun Kang, Jai Young Cho, Yoo‐Seok Yoon, Ho‐Seong Han, Jin‐Hyeok Hwang
SJR Q2Journal of Korean Medical ScienceOA

The role of carcinoembryonic antigen (CEA) in pancreatic cancer remains poorly understood. Therefore, this study aimed to determine whether CEA is complementary to carbohydrate antigen 19-9 (CA19-9) in prognosis prediction after pancreatic cancer curative resection. We retrospectively reviewed records of 144 stage II curatively resected pancreatic cancer patients with preoperative and postoperative CEA and CA19-9 levels. Patients with normal preoperative CA19-9 were excluded. R0 resection margin

OncologyMedicine
13
Article|20 citations·2021
Gender Differences in Patients with Metastatic Pancreatic Cancer Who Received FOLFIRINOX
Jinkook Kim, Jinkook Kim, Eunjeong Ji, Kwangrok Jung, In Ho Jung, Jaewoo Park, Jong-Chan Lee, Jin Won Kim, Jin Won Kim, Jin‐Hyeok Hwang, Jaihwan Kim, Jaihwan Kim
SJR Q2Journal of Personalized MedicineOA

Background: The combination of 5-fluorouracil, leucovorin, irinotecan, and oxaliplatin (FOLFIRINOX) is a very effective chemotherapeutic regimen for unresectable pancreatic cancer. Previous studies have reported that female gender may be a predictor of a better response to FOLFIRINOX. This study was aimed at investigating the clinical outcomes and dose modification patterns of FOLFIRINOX by gender. Methods: Patients with metastatic pancreatic cancer (MPC) who began FOLFIRINOX as the first-line t

OncologyMedicine
14
Review|19 citations·2015
Endoscopic Ultrasound-Guided Treatment of Pancreatic Cystic and Solid Masses
Jaihwan Kim
SJR Q2Clinical EndoscopyOA

Pancreatic tumor is one of the most difficult diseases to diagnose and treat because of its anatomical location and characteristics. Recently, there have been several innovative trials on the treatment of pancreatic tumors using endoscopic ultrasound (EUS) because it allows selective access to the difficult to reach target organ along the gastrointestinal tract and can differentiate vessels by color Doppler. Among these trials, several have investigated EUS-guided ethanol lavage with or without

OncologyMedicine
15
Article|18 citations·2020
Gemcitabine Plus Cisplatin Chemotherapy Prolongs the Survival in Advanced Hilar Cholangiocarcinoma
Dong Woo Shin, Min Jae Kim, Jong-Chan Lee, Jaihwan Kim, Sang Myung Woo, Woo Jin Lee, Kwang Hyuck Lee, Jin‐Hyeok Hwang
SJR Q3American Journal of Clinical Oncology

OBJECTIVES: Gemcitabine plus cisplatin (GC) is recommended as first-line treatment for advanced cholangiocarcinoma. We investigated the impact of GC in patients with unresectable hilar cholangiocarcinoma (HC) based on the time taken for effective biliary drainage (EBD). MATERIALS AND METHODS: We retrospectively enrolled 113 patients with unresectable HC. Thirty-nine and 74 patients received GC chemotherapy and best supportive care (BSC), respectively. EBD was defined as a reduction in total bili

SurgeryMedicine

Research Areas

OncologyPulmonary and Respiratory MedicineSurgeryEpidemiologyMolecular BiologyGastroenterology

Dive deeper into Jaihwan Kim's research on Nubint

Open this lab's papers in the app to read with AI, summarize, and cite in your writing.